Aperion Biologics, Inc. Receives Therapeutic Discovery Project Grant

9 November 2010

Aperion Biologics, Inc. (ABI), an orthobiologics company focused on regenerative medicine with a technology platform which provides unique solution to the global surgical need for human based grafts from an alternative source of tissue announced that the Company has received a grant totaling nearly $250,000 under the Qualifying Therapeutic Discovery Project.